Pharma IQ Members


Paul Freemont
As part of our Future Pharma series, Pharma IQ is examining the promise held by synthetic biology. Our editor spoke to Professor Paul Freemont Chair in Protein Crystallography and Co-Founder and Co-Director of the EPSRC Centre for Synthetic Biology and Innovation at Imperial College London. Professor Freemont Describes the current technical...Full Article »